)

Shionogi & Co (4507) investor relations material
Shionogi & Co Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Achieved year-on-year growth in revenue and all profit metrics for Q1 FY2025, driven by expansion of the HIV franchise and increased royalty income, despite declines in domestic and overseas drug sales.
Operating profit rose 24.9% to ¥35.1B, profit attributable to owners increased 28.5% to ¥39.4B, and EBITDA grew 22.8% to ¥40.6B.
Comprehensive income decreased to ¥44.4B from ¥62.8B year-over-year, mainly due to lower other comprehensive income.
Integration of JT Group's pharmaceutical business and acquisition of Torii Pharmaceutical are progressing, with full absorption expected by December 2025.
Submitted regulatory applications for ensitrelvir in the US and Europe, supporting medium- to long-term growth.
Financial highlights
Revenue for Q1 FY2025 was ¥99.8B, up 2.2% year-over-year; gross profit increased to ¥87.5B; gross margin improved.
Basic EPS was ¥46.26, up from ¥36.02 year-over-year, reflecting a 3-for-1 stock split.
Cash and cash equivalents at quarter-end were ¥254.8B, down ¥120.0B from the previous quarter.
Cost of sales decreased due to changes in product mix; SG&A increased from US business expansion, while R&D expenses fell.
Finance income rose on higher dividends from ViiV, reflecting strong HIV franchise sales.
Outlook and guidance
H1 forecast is expected to be achieved, driven by continued HIV franchise and cefiderocol growth, increased Xocova sales from COVID-19, and ongoing cost management.
Full-year revenue forecast is ¥530.0B, up 20.9% year-over-year; operating profit forecast is ¥175.0B, up 11.7%.
No revisions to the previously announced consolidated financial forecast.
Strategic R&D investments and M&A activities are prioritized to accelerate growth.
Basic EPS for the year ending March 31, 2026 is projected at ¥211.59.
Next Shionogi & Co earnings date

Next Shionogi & Co earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage